{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T11:57:51Z","timestamp":1794916671610,"version":"4.9.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002332","name":"Semmelweis University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002332","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Nasopharyngeal carriage of\n                    <jats:italic>Streptococcus pneumoniae<\/jats:italic>\n                    in children plays a key role in transmission and disease epidemiology, hence it is crucial to monitor colonisation. As PCV-15 has recently replaced PCV-13 in Hungary, the aim of the study was to survey colonisation epidemiology 12\u201313 years post-PCV-13. 401 children, attending day care centres at Northern Hungary (including Budapest) were screened between April 2022 and April 2023. The samples were collected with cotton swabs from both nostrils, the serotype and antibiotic susceptibility of the isolates was determined. Overall, the carriage rate was 16.5% (66\/401 children), which is lower compared to previous data from Hungary. Serotypes 23B, 35F, 15A\/F, 15B\/C, 11A and 23A were most prevalent. Non-vaccine types (NVTs) accounted for 68.2%, the coverage of PCV-13, PCV-15 and PCV-20 would be 9.1%, 10.6% and 31.8%, respectively. The resistance of the isolates to erythromycin, clindamycin and tetracycline was 12.1%, 7.6% and 10.6%, respectively and penicillin non-susceptibility was 24.2%. Serotypes 23B and 15A\/F and 35F contributed mostly to resistance. In summary, prevalence of NVTs is increasing and these are associated with higher resistance rates. Among vaccine types, those included in PCV-20 are most prevalent. Hence, vaccination with the highest coverage could be recommended.\n                  <\/jats:p>","DOI":"10.1038\/s41598-025-07777-x","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T20:21:05Z","timestamp":1751401265000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pneumococcal carriage among young children attending daycare in Hungary, 12\u201313 years post-PCV13: a cross-sectional study"],"prefix":"10.1038","volume":"15","author":[{"given":"Andrea","family":"Horv\u00e1th","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annam\u00e1ria","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1rp\u00e1d","family":"Bartha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Szofia","family":"Haj\u00f3si-Kalcakosz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Krist\u00f3f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orsolya","family":"Dobay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"7777_CR1","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1055\/s-0029-1202938","volume":"30","author":"JP Lynch","year":"2009","unstructured":"Lynch, J. P. & Zhanel, G. G. Streptococcus pneumoniae: epidemiology, risk factors, and strategies for prevention. Semin Respir Crit. Care Med. 30, 189\u2013209 (2009).","journal-title":"Semin Respir Crit. Care Med."},{"key":"7777_CR2","first-page":"85","volume":"94","author":"World Health Organization","year":"2019","unstructured":"World Health Organization. Pneumococcal conjugate vaccines in infants and children under 5 years of age: WHO position paper \u2013 February 2019. Wkly. Epidemiol. Rec. 94, 85\u2013104 (2019).","journal-title":"Wkly. Epidemiol. Rec"},{"key":"7777_CR3","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S1473-3099(04)00938-7","volume":"4","author":"D Bogaert","year":"2004","unstructured":"Bogaert, D., De Groot, R. & Hermans, P. W. Streptococcus pneumoniae colonisation: the key to Pneumococcal disease. Lancet Infect. Dis. 4, 144\u2013154 (2004).","journal-title":"Lancet Infect. Dis."},{"key":"7777_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41479-022-00097-y","volume":"14","author":"DM Musher","year":"2022","unstructured":"Musher, D. M., Anderson, R. & Feldman, C. The remarkable history of Pneumococcal vaccination: an ongoing challenge. Pneumonia (Nathan). 14, 5 (2022).","journal-title":"Pneumonia (Nathan)"},{"key":"7777_CR5","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3390\/vaccines9050420","volume":"9","author":"C Scelfo","year":"2021","unstructured":"Scelfo, C. et al. Pneumonia and invasive Pneumococcal diseases: the role of Pneumococcal conjugate vaccine in the era of multi-drug resistance. Vaccines (Basel). 9, 420 (2021).","journal-title":"Vaccines (Basel)"},{"key":"7777_CR6","doi-asserted-by":"publisher","first-page":"e0054021","DOI":"10.1128\/JCM.00540-21","volume":"59","author":"F Ganaie","year":"2021","unstructured":"Ganaie, F. et al. Structural, genetic, and serological Elucidation of Streptococcus pneumoniae serogroup 24 serotypes: discovery of a new serotype, 24\u00a0C, with a variable capsule structure. J. Clin. Microbiol. 59, e0054021 (2021).","journal-title":"J. Clin. Microbiol."},{"key":"7777_CR7","doi-asserted-by":"publisher","first-page":"e0305892","DOI":"10.1371\/journal.pone.0305892","volume":"20","author":"TM Malik","year":"2025","unstructured":"Malik, T. M. et al. A dynamic transmission model for assessing the impact of Pneumococcal vaccination in the united States. PLoS One. 20, e0305892 (2025).","journal-title":"PLoS One"},{"key":"7777_CR8","first-page":"141","volume":"16","author":"National Center for Epidemiology","year":"2009","unstructured":"National Center for Epidemiology. Pneumococcal vaccination in Europe. Epinfo 16, 141\u2013148 (2009).","journal-title":"Epinfo"},{"key":"7777_CR9","unstructured":"National Center for Epidemiology. Methodological letter of the National Center for Epidemiology about the vaccines in 2014. Epinfo 21 (special issue) (2014)."},{"key":"7777_CR10","first-page":"487","volume":"16","author":"National Center for Epidemiology","year":"2009","unstructured":"National Center for Epidemiology. Pneumococcal vaccination data in Hungary as in August 2009. Epinfo 16, 487\u2013492 (2009).","journal-title":"Epinfo"},{"key":"7777_CR11","unstructured":"http:\/\/www.antsz.hu\/data\/cms110646\/OSAP_Vedooltas_2023_honlapra.pdf."},{"key":"7777_CR12","doi-asserted-by":"crossref","unstructured":"Farina, S., Maio, A., Gualano, M. R., Ricciardi, W. & Villani, L. Childhood mandatory vaccinations: current situation in European countries and changes occurred from 2014 to 2024. Vaccines (Basel) 12, 1296 (2024).","DOI":"10.3390\/vaccines12111296"},{"key":"7777_CR13","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1017\/S0950268815002757","volume":"144","author":"A T\u00f3thp\u00e1l","year":"2016","unstructured":"T\u00f3thp\u00e1l, A. et al. Epidemiological analysis of Pneumococcal serotype 19A in healthy children following PCV7 vaccination. Epidemiol. Infect. 144, 1563\u20131573 (2016).","journal-title":"Epidemiol. Infect."},{"key":"7777_CR14","doi-asserted-by":"publisher","first-page":"4565","DOI":"10.1016\/j.vaccine.2016.07.031","volume":"34","author":"A Lindstrand","year":"2016","unstructured":"Lindstrand, A. et al. Unaltered Pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8 years after vaccine introduction in stockholm, Sweden. Vaccine 34, 4565\u20134571 (2016).","journal-title":"Vaccine"},{"key":"7777_CR15","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s00431-014-2408-1","volume":"174","author":"A T\u00f3thp\u00e1l","year":"2015","unstructured":"T\u00f3thp\u00e1l, A. et al. Radical serotype rearrangement of carried Pneumococci in the first 3 years after intensive vaccination started in Hungary. Eur. J. Pediatr. 174, 373\u2013381 (2015).","journal-title":"Eur. J. Pediatr."},{"key":"7777_CR16","doi-asserted-by":"publisher","first-page":"e0229021","DOI":"10.1371\/journal.pone.0229021","volume":"15","author":"E Kov\u00e1cs","year":"2020","unstructured":"Kov\u00e1cs, E. et al. Co-carriage of Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis among three different age categories of children in Hungary. PLoS One. 15, e0229021 (2020).","journal-title":"PLoS One"},{"key":"7777_CR17","doi-asserted-by":"publisher","first-page":"2041","DOI":"10.1016\/j.vaccine.2021.03.028","volume":"39","author":"M Ceyhan","year":"2021","unstructured":"Ceyhan, M. et al. Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children aged less than five years. Vaccine 39, 2041\u20132047 (2021).","journal-title":"Vaccine"},{"key":"7777_CR18","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1186\/s12879-017-2816-8","volume":"17","author":"L Wang","year":"2017","unstructured":"Wang, L., Fu, J., Liang, Z. & Chen, J. Prevalence and serotype distribution of nasopharyngeal carriage of Streptococcus pneumoniae in China: a meta-analysis. BMC Infect. Dis. 17, 765 (2017).","journal-title":"BMC Infect. Dis."},{"key":"7777_CR19","doi-asserted-by":"publisher","first-page":"4106","DOI":"10.1016\/j.vaccine.2023.05.042","volume":"41","author":"BE Gonzales","year":"2023","unstructured":"Gonzales, B. E. et al. Pneumococcal serotypes and antibiotic resistance in healthy carriage children after introduction of PCV13 in lima, Peru. Vaccine 41, 4106\u20134113 (2023).","journal-title":"Vaccine"},{"key":"7777_CR20","doi-asserted-by":"publisher","first-page":"e39730","DOI":"10.1371\/journal.pone.0039730","volume":"7","author":"J Spijkerman","year":"2012","unstructured":"Spijkerman, J. et al. Long-term effects of Pneumococcal conjugate vaccine on nasopharyngeal carriage of S. pneumoniae, S. aureus, H. influenzae and M. catarrhalis. PLoS One. 7, e39730 (2012).","journal-title":"PLoS One"},{"key":"7777_CR21","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.vaccine.2015.11.060","volume":"34","author":"AATM Bosch","year":"2016","unstructured":"Bosch, A. A. T. M. et al. Nasopharyngeal carriage of Streptococcus pneumoniae and other bacteria in the 7th year after implementation of the Pneumococcal conjugate vaccine in the Netherlands. Vaccine 34, 531\u2013539 (2016).","journal-title":"Vaccine"},{"key":"7777_CR22","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3390\/antibiotics12061020","volume":"12","author":"A Rybak","year":"2023","unstructured":"Rybak, A. et al. Dynamics of antibiotic resistance of Streptococcus pneumoniae in France: a pediatric prospective nasopharyngeal carriage study from 2001 to 2022. Antibiot. (Basel). 12, 1020 (2023).","journal-title":"Antibiot. (Basel)"},{"key":"7777_CR23","doi-asserted-by":"publisher","first-page":"126219","DOI":"10.1016\/j.vaccine.2024.126219","volume":"42","author":"C Candeias","year":"2024","unstructured":"Candeias, C. et al. Streptococcus pneumoniae carriage, serotypes, genotypes, and antimicrobial resistance trends among children in portugal, after introduction of PCV13 in National immunization program: A cross-sectional study. Vaccine 42, 126219 (2024).","journal-title":"Vaccine"},{"key":"7777_CR24","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1093\/cid\/ciaa917","volume":"72","author":"R Cohen","year":"2021","unstructured":"Cohen, R. et al. Invasive disease potential of Pneumococcal serotypes in children after PCV13 implementation. Clin. Infect. Dis. 72, 1453\u20131456 (2021).","journal-title":"Clin. Infect. Dis."},{"key":"7777_CR25","unstructured":"European Centre for Disease Prevention and Control. Surveillance Atlas of Infectious Diseases. https:\/\/www.ecdc.europa.eu\/en\/surveillance-atlas-infectious-diseases."},{"key":"7777_CR26","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.vaccine.2018.11.026","volume":"37","author":"E Kov\u00e1cs","year":"2019","unstructured":"Kov\u00e1cs, E. et al. Vaccine-driven serotype-rearrangement is seen with latency in clinical isolates: comparison of carried and clinical Pneumococcal isolates from the same time period in Hungary. Vaccine 37, 99\u2013108 (2019).","journal-title":"Vaccine"},{"key":"7777_CR27","doi-asserted-by":"publisher","first-page":"6126","DOI":"10.1016\/j.vaccine.2016.10.050","volume":"34","author":"G Oligbu","year":"2016","unstructured":"Oligbu, G., Hsia, Y., Folgori, L., Collins, S. & Ladhani, S. Pneumococcal conjugate vaccine failure in children: A systematic review of the literature. Vaccine 34, 6126\u20136132 (2016).","journal-title":"Vaccine"},{"key":"7777_CR28","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.vaccine.2017.12.035","volume":"36","author":"PP Gounder","year":"2018","unstructured":"Gounder, P. P. et al. Re-emergence of Pneumococcal colonization by vaccine serotype 19F in persons aged\u2009\u2265\u20095 years after 13-valent Pneumococcal conjugate vaccine introduction-Alaska, 2008\u20132013. Vaccine 36, 691\u2013697 (2018).","journal-title":"Vaccine"},{"key":"7777_CR29","unstructured":"European Centre for Disease Prevention and Control. Invasive pneumococcal disease. In ECDC. Annual Epidemiological Report for 2022. Stockholm. https:\/\/ecdc.europa.eu\/ (2025)."},{"key":"7777_CR30","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.vaccine.2013.05.005","volume":"32","author":"SM Davis","year":"2013","unstructured":"Davis, S. M., Deloria-Knoll, M., Kassa, H. T. & O\u2019Brien, K. L. Impact of Pneumococcal conjugate vaccines on nasopharyngeal carriage and invasive disease among unvaccinated people: review of evidence on indirect effects. Vaccine 32, 133\u2013145 (2013).","journal-title":"Vaccine"},{"key":"7777_CR31","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1007\/s40121-023-00828-8","volume":"12","author":"M Wilson","year":"2023","unstructured":"Wilson, M. et al. Assessing public health impact of four pediatric Pneumococcal conjugate vaccination strategies in the Netherlands. Infect. Dis. Ther. 12, 1809\u20131821 (2023).","journal-title":"Infect. Dis. Ther."},{"key":"7777_CR32","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.eimc.2022.11.005","volume":"42","author":"B de Felipe","year":"2024","unstructured":"de Felipe, B. et al. Molecular epidemiology of Pneumococcal carriage in children from seville, following implementation of the PCV13 immunization program in andalusia, Spain. Enferm Infecc Microbiol. Clin. (Engl Ed). 42, 172\u2013178 (2024).","journal-title":"Enferm Infecc Microbiol. Clin. (Engl Ed)"},{"key":"7777_CR33","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1093\/infdis\/jiac154","volume":"226","author":"KL Bajema","year":"2022","unstructured":"Bajema, K. L. et al. Impact of Pneumococcal conjugate vaccines on antibiotic-nonsusceptible invasive Pneumococcal disease in the United States. J. Infect. Dis. 226, 342\u2013351 (2022).","journal-title":"J. Infect. Dis."},{"key":"7777_CR34","unstructured":"National Bacteriological Surveillance Management Team. NBS Annual Reports. National Center for Public Health and & Pharmacy, Budapest, Hungary. https:\/\/www.nnk.gov.hu\/index.php\/mikrobiologiai-referencia-laboratoriumi-foosztaly\/nemzeti-bakteriologiai-surveillance-nbs\/category\/348-streptococcus-pneumoniae.html (2024)."},{"key":"7777_CR35","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.jinf.2020.07.035","volume":"81","author":"JA Suaya","year":"2020","unstructured":"Suaya, J. A. et al. Streptococcus pneumoniae serotype distribution and antimicrobial nonsusceptibility trends among adults with pneumonia in the United States, 2009\u20132017. J. Infect. 81, 557\u2013566 (2020).","journal-title":"J. Infect."},{"key":"7777_CR36","unstructured":"https:\/\/www.ksh.hu\/interaktiv\/korfak\/orszag.html."},{"key":"7777_CR37","unstructured":"https:\/\/www.ksh.hu\/stadat_files\/nep\/hu\/nep0003.html."},{"key":"7777_CR38","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1093\/jac\/48.6.915","volume":"48","author":"K Nagai","year":"2001","unstructured":"Nagai, K. et al. Evaluation of PCR primers to screen for Streptococcus pneumoniae isolates and beta-lactam resistance, and to detect common macrolide resistance determinants. J. Antimicrob. Chemother. 48, 915\u2013918 (2001).","journal-title":"J. Antimicrob. Chemother."},{"key":"7777_CR39","unstructured":"CDC. Streptococcus pneumoniae Detection and Serotyping Using PCR. https:\/\/www.cdc.gov\/strep-lab\/php\/pneumococcus\/serotyping-using-pcr.html."},{"key":"7777_CR40","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1128\/JCM.41.6.2378-2384.2003","volume":"41","author":"DA Brito","year":"2003","unstructured":"Brito, D. A., Ramirez, M. & de Lencastre, H. Serotyping Streptococcus pneumoniae by multiplex PCR. J. Clin. Microbiol. 41, 2378\u20132384 (2003).","journal-title":"J. Clin. Microbiol."},{"key":"7777_CR41","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1556\/AMicr.56.2009.4.3","volume":"56","author":"O Dobay","year":"2009","unstructured":"Dobay, O. et al. Taguchi optimisation of a multiplex Pneumococcal serotyping PCR and description of 11 novel serotyping primers. Acta Microbiol. Immunol. Hung. 56, 327\u2013338 (2009).","journal-title":"Acta Microbiol. Immunol. Hung."},{"key":"7777_CR42","unstructured":"EUCAST: The European Committee on Antimicrobial Susceptibility Testing. Breakpoint Tables for Interpretation of MICs and Zone Diameters. Version 14.0 (2024)."},{"key":"7777_CR43","doi-asserted-by":"publisher","first-page":"124","DOI":"10.12688\/wellcomeopenres.14826.1","volume":"3","author":"KA Jolley","year":"2018","unstructured":"Jolley, K. A., Bray, J. E. & Maiden, M. C. J. Open-access bacterial population genomics: BIGSdb software, the pubmlst.org website and their applications. Wellcome Open. Res. 3, 124 (2018).","journal-title":"Wellcome Open. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07777-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07777-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07777-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T20:21:09Z","timestamp":1751401269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-07777-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7777"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-07777-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22696"}}